Find link

language:

Find link is a tool written by Edward Betts.

searching for LNCaP 63 found (88 total)

alternate case: lNCaP

UGT2B15 (867 words) [view diff] exact match in snippet view article find links to article

diphospho-glucuronosyltransferases, UGT2B15 and UGT2B17, in human prostate LNCaP cells". Endocrinology. 138 (7): 2998–3005. doi:10.1210/endo.138.7.5226.

Piscarinine (159 words) [view diff] case mismatch in snippet view article find links to article

piscarinines A and B were shown to be active against the prostate cancer cell line LNCAP (IC50 values were 2.2 and 1.9 μg/mL for piscarinine A and B, respectively)

GPR31 (1,651 words) [view diff] exact match in snippet view article find links to article

in human prostate cancer. However, LNCaP and PC3 human prostate cancer cells also express BLT2 receptors; in LNCaP cells, BLT2 receptors stimulate the

40S ribosomal protein S3a (1,051 words) [view diff] exact match in snippet view article find links to article

monophosphate induced neuroendocrine differentiation of LNCaP cells. Regulation of S3a gene expression in LNCaP". Mol. Biol. Rep. 29 (3): 301–16. doi:10.1023/A:1020457400377

UGT2B17 (644 words) [view diff] exact match in snippet view article find links to article

enzymes are major determinants of the androgen response in prostate cancer LNCaP cells". J. Biol. Chem. 282 (46): 33466–74. doi:10.1074/jbc.M703370200. PMID 17848572

List of 5α-reductase inhibitors (3,034 words) [view diff] exact match in snippet view article find links to article

Kim K, Mar W (February 2002). "Inhibitors of 5alpha -reductase type I in LNCaP cells from the roots of Angelica koreana". Planta Medica. 68 (2): 162–3

Drupanol (161 words) [view diff] exact match in snippet view article find links to article

inhibits the androgen induced-proliferation of prostate cancer cell line LNCaP through suppression of AR transcription activity". Tianjin Journal of Traditional

Stephacidin (516 words) [view diff] exact match in snippet view article find links to article

structurally novel, selective inhibitors of the testosterone-dependent prostate LNCaP cells". Journal of the American Chemical Society. 124 (49): 14556–14557

Bakuchiol (1,649 words) [view diff] exact match in snippet view article find links to article

inhibits the androgen induced-proliferation of prostate cancer cell line LNCaP through suppression of AR transcription activity". Tianjin Journal of Traditional

Long-chain-fatty-acid—CoA ligase (2,740 words) [view diff] exact match in snippet view article find links to article

contributes to vitamin D3 growth inhibitory effect in human prostate cancer LNCaP cells. A current study reports that the feedback inhibition of FAS expression

12-Hydroxyeicosatetraenoic acid (6,987 words) [view diff] exact match in snippet view article find links to article

pro-malignant activity of 12(S)-HETE. However, LNCaP and PC3 cells also express BLT2 receptors; in LNCaP cells, BLT2 receptors are positively linked (i

IRX5 (437 words) [view diff] exact match in snippet view article find links to article

in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells". Clinical Cancer Research. 14 (11): 3562–70. doi:10

KLK2 (1,089 words) [view diff] exact match in snippet view article find links to article

"Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells". Oncogene. 19 (15): 1924–1932. doi:10.1038/sj.onc

Glutamate carboxypeptidase II (4,325 words) [view diff] exact match in snippet view article find links to article

accomplished with RNA from a prostate tumor cell line, LNCaP. PSMA was first detected in the LNCaP cell line using the murine monoclonal antibody 7E11-C5

Diazepam binding inhibitor (970 words) [view diff] exact match in snippet view article find links to article

inhibitor/acyl-CoA-binding protein in the human prostatic adenocarcinoma cell line LNCaP". Mol. Cell. Endocrinol. 104 (2): 153–162. doi:10.1016/0303-7207(94)90118-X

Liver X receptor (3,038 words) [view diff] exact match in snippet view article find links to article

(November 2004). "Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells". Cancer Res. 64 (21): 7686–9. doi:10.1158/0008-5472

Zinc transporter 1 (725 words) [view diff] exact match in snippet view article find links to article

and expression of zinc transporters in androgen-independent subline of LNCaP cells". J. Androl. 25 (1): 154–61. doi:10.1002/j.1939-4640.2004.tb02771

SLC45A3 (717 words) [view diff] exact match in snippet view article find links to article

gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells". Journal of Molecular Medicine. 86 (3): 313–22. doi:10.1007/s00109-007-0296-9

CYP7B1 (1,147 words) [view diff] exact match in snippet view article find links to article

steroid hydroxylase CYP7B1 by androgens and estrogens in prostate cancer LNCaP cells". Biochem. Biophys. Res. Commun. 344 (2): 540–6. doi:10.1016/j.bbrc

VIPR2 (1,889 words) [view diff] exact match in snippet view article find links to article

Gutiérrez-Cañas I, et al. (2002). "Neuroendocrine differentiation of the LNCaP prostate cancer cell line maintains the expression and function of VIP and

CMTM3 (1,625 words) [view diff] exact match in snippet view article find links to article

reduced in prostate cancer and inhibits migration, invasion and growth of LNCaP cells". Clinical & Translational Oncology. 17 (8): 632–9. doi:10.1007/s12094-015-1288-9

Mir-126 (2,258 words) [view diff] exact match in snippet view article find links to article

gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells". Journal of Molecular Medicine. 86 (3): 313–22. doi:10.1007/s00109-007-0296-9

IFITM3 (599 words) [view diff] exact match in snippet view article find links to article

Porvari K, Kyllönen A, Vihko P (2000). "Differentially expressed genes in two LNCaP prostate cancer cell lines reflecting changes during prostate cancer progression"

Topilutamide (762 words) [view diff] exact match in snippet view article find links to article

Percentage androgen receptor suppression in LNCaP Cells after 48-h Drug Incubation via Western Blot Compound 3 μM 10 μM BP-766 (Topilutamide) 41 ± 5 95

PCGEM1 (467 words) [view diff] exact match in snippet view article find links to article

Romanuik TL, Wang G, Morozova O, Delaney A, Marra MA, Sadar MD (2010). "LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent

Androgen receptor (9,376 words) [view diff] exact match in snippet view article find links to article

androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaP". The Journal of Biological Chemistry. 272 (28): 17485–94. doi:10.1074/jbc

FGF9 (1,756 words) [view diff] exact match in snippet view article find links to article

induced by fibroblast growth factors in the prostatic carcinoma cell line LNCaP but not in normal primary prostate epithelial cells". The Prostate. 41 (4):

Androprostamine (392 words) [view diff] case mismatch in snippet view article find links to article

inhibition against androgen-dependent proliferation of human prostate cancer LNCap and VCaP cells. Androprostamine A has been further studied in cancer since

Nelfinavir (1,437 words) [view diff] exact match in snippet view article find links to article

inhibitor induces growth arrest and apoptosis of human prostate cancer LNCaP cells in vitro and in vivo in conjunction with blockade of androgen receptor

SELENBP1 (723 words) [view diff] exact match in snippet view article find links to article

Mulder E (March 1992). "Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction

STK39 (605 words) [view diff] exact match in snippet view article find links to article

"Androgens induce expression of SPAK, an STE20/SPS1-related kinase, in LNCaP human prostate cancer cells". Mol. Cell. Endocrinol. 182 (2): 181–92. doi:10

PPAP2A (886 words) [view diff] exact match in snippet view article find links to article

androgen-regulated gene in the human prostatic adenocarcinoma cell line LNCaP". J. Biol. Chem. 273 (8): 4660–4665. doi:10.1074/jbc.273.8.4660. PMID 9468526

Survivin (8,387 words) [view diff] exact match in snippet view article find links to article

cells.) Zhang et al. first assessed the level of survivin expression of LNCaP (an androgen-dependent prostate cancer cell line that expresses intact androgen

Khalid Zaffar Masoodi (2,366 words) [view diff] exact match in snippet view article find links to article

effectively. Two of the extracts were tested in human xenograft C4-2/Relapsed LNCaP human xenograft model and found effective in inhibiting growth of tumors

17α-Ethynyl-3α-androstanediol (377 words) [view diff] exact match in snippet view article find links to article

D, Reading C, Frincke J (2009). "Inhibition of androstenediol-dependent LNCaP tumour growth by 17alpha-ethynyl-5alpha-androstane-3alpha, 17beta-diol (HE3235)"

MIZF (763 words) [view diff] exact match in snippet view article find links to article

island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding

Catenin (3,567 words) [view diff] exact match in snippet view article find links to article

Wnt/β-catenin signaling pathway, thus enhancing the invasive potential of LNCaP cells (human prostate cancer cells). As a result, it is possible that the

Indole-3-carbinol (1,618 words) [view diff] exact match in snippet view article find links to article

Firestone, G. (2006). "Indole-3-carbinol mediated cell cycle arrest of LNCaP human prostate cancer cells requires the induced production of activated

ERBB3 (2,816 words) [view diff] exact match in snippet view article find links to article

pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells". Cancer Research. 59 (12): 2891–2897. PMID 10383151

HSPA1A (3,267 words) [view diff] exact match in snippet view article find links to article

Mulder E (1992). "Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction

MicroRNA 148a (694 words) [view diff] exact match in snippet view article find links to article

Inoue S (2010). "miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression". Prostate

ACAT1 (2,322 words) [view diff] exact match in snippet view article find links to article

Nelson CC, et al. (2008). "Androgen-mediated cholesterol metabolism in LNCaP and PC-3 cell lines is regulated through two different isoforms of acyl-coenzyme

Transcription factor Jun (5,452 words) [view diff] exact match in snippet view article find links to article

androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaP". The Journal of Biological Chemistry. 272 (28): 17485–94. doi:10.1074/jbc

PTPRK (4,376 words) [view diff] exact match in snippet view article find links to article

shown to be downregulated in response to androgen stimulation in human LNCaP prostate cancer cells. The mechanism whereby PTPRK is downregulated is via

PIK3R1 (3,136 words) [view diff] exact match in snippet view article find links to article

pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells". Cancer Res. 59 (12): 2891–7. PMID 10383151

PELP-1 (3,909 words) [view diff] exact match in snippet view article find links to article

androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence". Cancer Research. 64 (19): 7156–68. doi:10

Platinum nanoparticle (5,347 words) [view diff] exact match in snippet view article find links to article

nanoparticle to move an antitumor drug, Cisplatin, within a prostate cancer cell (LNCaP/PC3) population. Use of platinum in drug delivery hinges on its ability

KHDRBS1 (2,812 words) [view diff] exact match in snippet view article find links to article

splicing. Subsequently, the knockdown of Sam68 has been shown to delay LNCaP prostate cancer cells proliferation. In addition, Sam68 in conjunction with

Lentiviral vector in gene therapy (3,448 words) [view diff] exact match in snippet view article find links to article

transformed by being bound to trastuzumab to attach to androgen-sensitive LNCaP and castration-resistant C4-2 human prostate cancer cell lines. These two

RNF113A (2,091 words) [view diff] exact match in snippet view article find links to article

phosphoproteome in prostate cancer cells: Identification of phosphoproteins in the LNCaP cell line". Electrophoresis. 28 (12): 2027–2034. doi:10.1002/elps.200600782

STAU1 (2,556 words) [view diff] exact match in snippet view article find links to article

formation in vivo. Downregulation of STAU1 in prostate cancer cell line LNCaP inhibits proliferation of these cells without inducing apoptosis. STAU1

RNA-Seq (11,098 words) [view diff] exact match in snippet view article find links to article

A, et al. (September 2006). "Analysis of the prostate cancer cell line LNCaP transcriptome using a sequencing-by-synthesis approach". BMC Genomics. 7:

1-Deoxysphingolipids (2,298 words) [view diff] exact match in snippet view article find links to article

Ana (28 Apr 2008). "Spisulosine (ES-285) induces prostate tumor PC-3 and LNCaP cell death by de novo synthesis of ceramide and PKCzeta activation". Retrieved

Heat shock protein 90kDa alpha (cytosolic), member A1 (8,199 words) [view diff] exact match in snippet view article

Mulder E (Mar 1992). "Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction

NEDD4L (3,265 words) [view diff] exact match in snippet view article find links to article

"Androgens differentially regulate the expression of NEDD4L transcripts in LNCaP human prostate cancer cells". Mol. Cell. Endocrinol. 210 (1–2): 51–62. doi:10

TRPV6 (10,475 words) [view diff] case mismatch in snippet view article find links to article

and prostate cancer cell lines. The prostate cancer cell lines PC-3 and LnCAP overexpress TRPV6 relative to benign epithelial cells PrEC and BPH-1. The

Systematic evolution of ligands by exponential enrichment (4,747 words) [view diff] exact match in snippet view article find links to article

"ADAPT identifies an ESCRT complex composition that discriminates VCaP from LNCaP prostate cancer cell exosomes". Nucleic Acids Research. 48 (8): 4013–4027

Transcriptomics technologies (12,516 words) [view diff] exact match in snippet view article find links to article

Jones SJ (September 2006). "Analysis of the prostate cancer cell line LNCaP transcriptome using a sequencing-by-synthesis approach". BMC Genomics. 7:

Prostasomes (2,484 words) [view diff] case mismatch in snippet view article find links to article

prostasome-like granules by the prostate cancer cell lines PC3, Du145 and LnCaP grown in monolayer". Upsala Journal of Medical Sciences. 104 (3): 199–206

Picropodophyllin (1,247 words) [view diff] exact match in snippet view article find links to article

"Picropodophyllin Inhibits the Proliferation of Human Prostate Cancer DU145 and LNCaP Cells via ROS Production and PI3K/AKT Pathway Inhibition". Biological and

Embryonal fyn-associated substrate (4,850 words) [view diff] exact match in snippet view article find links to article

EFS expression also correlated with malignant behavior of the PC-3 and LNCaP prostate cancer cells. In another study, methylation of the EFS CpG island

Pharmacology of bicalutamide (20,418 words) [view diff] exact match in snippet view article find links to article

comparison of the effects of bicalutamide treatment and AR knockdown by siRNA in LNCaP cells, using a limited gene array, demonstrates that the two treatments

TMEM211 (9,001 words) [view diff] exact match in snippet view article find links to article

25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells". Molecular Cancer. 10 (1): 58. doi:10.1186/1476-4598-10-58. PMC 3112430